Ortho Biotech Seeks FDA Approval For DOXIL(R) In Combination With VELCADE(R) To Treat Relapsed/Refractory Multiple Myeloma

... Ortho Biotech Products, L.P., today announced that the U.S. Food and Drug Administration (FDA) has accepted an application for DOXIL(R) (doxorubicin HCl liposome injection) as combination therapy with VELCADE(R) (bortezomib) for injection to treat patients with multiple myeloma who have received at least one prior therapy. [click link for full article] ...